Document Detail

Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
MedLine Citation:
PMID:  23165463     Owner:  NLM     Status:  MEDLINE    
M Shoai Tehrani; F Sicre de Fontbrune; P Roth; C Allisy; M-E Bougnoux; O Hermine; M Lecuit; O Lortholary; C Charlier
Related Documents :
3299183 - Relationship between fetal growth and maternal fructosamine in diabetic pregnancy.
12521823 - Preliminary experience with the use of insulin lispro in pregnant diabetic women.
23656393 - Assisted reproductive technique increases the risk of placental polyp.
Publication Detail:
Type:  Case Reports; Letter     Date:  2012-11-19
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  57     ISSN:  1098-6596     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-23     Completed Date:  2013-07-29     Revised Date:  2013-08-12    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1094-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspergillosis / drug therapy*
Aspergillus flavus / drug effects,  isolation & purification
Pregnancy Trimester, Third
Pyrimidines / adverse effects*,  pharmacology,  therapeutic use*
Triazoles / adverse effects*,  pharmacology,  therapeutic use*
Reg. No./Substance:
0/Pyrimidines; 0/Triazoles; 0/voriconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing sche...
Next Document:  Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis.